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A 48-year-old male with a previous history of thymectomy 
for thymoma, on intravenous immunoglobulin therapy, in 
remission, presented in emergency room with new onset 
of forgetfulness, disorientation and altered behaviour for 
2 weeks. The blood investigations were significant for 
low lymphocyte count 0.9 U/uL × 1000 U/uL. Computed 
tomography (CT) brain was performed to evaluate for 
possible metastasis or ischaemia.
The CT brain revealed a large confluent non-enhancing 
hypoattenuation region in the left frontal lobe, centrum 
semiovale and external capsule, involving the subcortical 
and deep white matter with sparing of the overlying cortex, 
also extending to the contralateral right frontal lobe across 
the genu of the corpus callosum [Figure 1]. No associated 
mass effect or contrast enhancement was visualized. CT 
findings were suggestive of white matter disease such as 
demyelinating disease and further characterization with 
magnetic resonance imaging (MRI) was advised.
The MRI brain confirmed the findings of CT with confluent 
T2/fluid-attenuated inversion recovery (FLAIR) increased 
signal intensity in the left frontal lobe, involving the 
subcortical and deep white matter with sparing of the 
cortex, tracking along the genu of the corpus callosum to 
the contralateral right frontal lobe. There was involvement 
of subcortical U-fibres [Figure 2]. No mass effect, diffusion 
restriction or post-contrast enhancement were noticed [Figures 
3 and 4]. Imaging findings were in favour of pure white matter 
disease such as progressive multifocal leukoencephalopathy 
(PML) in a patient with deficient cell-mediated immunity.
Other diseases can give similar appearance on imaging 
in immunocompromised patients such as immune 
reconstitution inflammatory syndrome (IRIS) which can 
show intense irregular rim enhancement and diffusion 
restriction at the periphery.[1] IRIS is seen in HIV-infected 
patients and patients getting PML-inducing immune 
therapy.[2]
Toxoplasmosis demonstrates ring enhancement 
and mass effect in the periventricular location. 
Cytomegalovirus infection can show ependymitis or 
ventriculitis.[1] HIV encephalopathy has more confluent 
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Figure 2: Axial fluid-attenuated inversion recovery magnetic 
resonance images demonstrate confluent high-signal intensity 
region in the left frontal lobe involving the subcortical and deep 
white matter, extending to the left external capsule left centrum 
semiovale and right frontal lobe across the genu of the corpus 
callosum
Figure 1: (a and b) Axial enhanced and unenhanced computed 
tomography images of the brain show hypodense region in the 
left frontal lobe subcortical and periventricular white matter 
(red arrow)
a b
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symmetric periventricular distribution associated with 
brain atrophy.
PML is a disease involving central nervous system when 
there is the destruction of oligodendrocytes by John 
Cunningham (JC) virus.[3] It is a type of opportunistic 
infection in immunocompromised patients such as HIV 
infection, lymphomas, organ/stem cell transplantation 
and patients who are subjected to immune therapies with 
monoclonal antibodies like natalizumab.
PML classically shows T1 hypointense and T2/FLAIR 
hyperintense asymmetric multifocal periventricular and 
subcortical white matter involvement on MRI. It has 
predilection for parietooccipital areas with more common 
involvement of subcortical U-fibres. No mass effect or 
contrast enhancement is observed and cortex is usually 
spared. PML-IRIS, a similar disease seen in AIDS patients 
on HAART or natalizumab therapy, there is post-contrast 
enhancement in these white matter changes. It may be 
considered as a sign of better survival. Diffusion-weighted 
image sequences show patchy diffusion restriction in the 
periphery of these white matter changes.
Definitive diagnosis of PML is based on histopathology 
which includes findings such as demyelination, bizarre 
astrocytes, enlarged oligodendroglial nuclei and presence 
of JC virus. Another diagnostic tool is the presence of JC 
virus in cerebrospinal fluid (CSF). It is detected by PCR. 
A number of authorities regard the demonstration of JC 
viral DNA in CSF coupled with the appropriate clinical 
and radiologic features, sufficient to diagnose PML, thus 
obviating the need for brain biopsy.[4] Therefore, clinical, 
radiologic and laboratory evidence are essential to establish 
diagnosis.
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Figure 3: Axial and sagittal T1 post-gadolinium magnetic 
resonance images show no contrast enhancement or mass effect
Figure 4: Axial diffusion-weighted image magnetic resonance 
image shows no diffusion restriction
